ACTA1 and Hepatic fibrosis: Yu et al. showed that the process of liver fibrosis is accompanied by a decrease in MEG3 in vivo and in vitro and that restoration of MEG3 expression inhibits liver fibrosis while reducing α-SMA and type I collagen production (Yu et al., 2018).